Hillhurst Biopharmaceuticals, Inc. STTR Phase I Award, August 2022
A STTR Phase I contract was awarded to Hillhurst Biopharmaceuticals, Inc. in August, 2022 for $299,894.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Name
# Contributions
Last Contribution
Find more entities like Hillhurst Biopharmaceuticals, Inc. STTR Phase I Award, August 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.